P. Farahani, “NON-SEVERE HYPOGLYCEMIA RISK DIFFERENCE BETWEEN SULFONYLUREA AND SODIUM-GLUCOSE COTRANSPORTER-2 INHIBITORS (SGLT2-I) AS AN ADD-ON TO METFORMIN IN RANDOMIZED CONTROLLED TRIALS”, J Popl Ther Clin Pharmacol, vol. 24, no. 2, pp. e32-e40, Jun. 2017.